Trial intelligence / Profile preview

Hycos MG500 I skin regeneration study in patients with pressure ulcers or wounds

RBR-547cnx9Recruiting

Sponsor
Nipo Serviços Médicos
Start
May 2024
Countries
1
01

Overview

Single-blind, single-arm trial in decubitus ulcer and cutaneous wound, sponsored by Nipo Serviços Médicos. Primary endpoints: Efficacy of skin regeneration and Safety of Hycos MG500 I. Started May 2024; status: recruiting.

02

Conditions

decubitus ulcercutaneous wound

Beyond the preview

Go deeper on RBR-547cnx9.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-547cnx9.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call